Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48 INR | +2.15% | +0.02% | +68.48% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 87.56 | 67.52 | 46.97 | 51.65 | 194 | 123.6 |
Enterprise Value (EV) 1 | 83.92 | 72.51 | 72.51 | 86.15 | 245.7 | 176 |
P/E ratio | 32.3 x | 15.7 x | 17.1 x | -2.05 x | 22.2 x | -7.4 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.3 x | 0.22 x | 0.13 x | 0.21 x | 0.48 x | 0.26 x |
EV / Revenue | 0.29 x | 0.23 x | 0.19 x | 0.34 x | 0.61 x | 0.38 x |
EV / EBITDA | 26 x | 14.9 x | 10.6 x | -2.92 x | 22 x | -8.15 x |
EV / FCF | 1.52 x | -6 x | -3.26 x | -10.7 x | -7.43 x | 84.1 x |
FCF Yield | 65.7% | -16.7% | -30.7% | -9.39% | -13.5% | 1.19% |
Price to Book | 0.84 x | 0.62 x | 0.42 x | 0.67 x | 2.27 x | 1.8 x |
Nbr of stocks (in thousands) | 7,420 | 7,420 | 7,420 | 7,420 | 7,420 | 7,420 |
Reference price 2 | 11.80 | 9.100 | 6.330 | 6.960 | 26.15 | 16.66 |
Announcement Date | 8/21/18 | 8/13/19 | 7/29/20 | 8/11/21 | 8/1/22 | 8/1/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 290.1 | 310.3 | 375.4 | 251.8 | 401.3 | 467.8 |
EBITDA 1 | 3.232 | 4.861 | 6.831 | -29.46 | 11.18 | -21.59 |
EBIT 1 | 1.38 | 2.748 | 4.415 | -31.23 | 8.416 | -25.24 |
Operating Margin | 0.48% | 0.89% | 1.18% | -12.4% | 2.1% | -5.39% |
Earnings before Tax (EBT) 1 | 3.253 | 3.458 | 4.359 | -25.32 | 7.466 | -28.94 |
Net income 1 | 2.708 | 4.326 | 2.762 | -25.2 | 8.723 | -16.72 |
Net margin | 0.93% | 1.39% | 0.74% | -10.01% | 2.17% | -3.57% |
EPS 2 | 0.3649 | 0.5800 | 0.3700 | -3.400 | 1.176 | -2.253 |
Free Cash Flow 1 | 55.15 | -12.08 | -22.27 | -8.087 | -33.07 | 2.094 |
FCF margin | 19.01% | -3.89% | -5.93% | -3.21% | -8.24% | 0.45% |
FCF Conversion (EBITDA) | 1,706.34% | - | - | - | - | - |
FCF Conversion (Net income) | 2,036.49% | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 8/21/18 | 8/13/19 | 7/29/20 | 8/11/21 | 8/1/22 | 8/1/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 4.99 | 25.5 | 34.5 | 51.6 | 52.4 |
Net Cash position 1 | 3.64 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 1.026 x | 3.739 x | -1.171 x | 4.62 x | -2.428 x |
Free Cash Flow 1 | 55.1 | -12.1 | -22.3 | -8.09 | -33.1 | 2.09 |
ROE (net income / shareholders' equity) | 2.65% | 4.07% | 2.52% | -26.8% | 10.8% | -21.7% |
ROA (Net income/ Total Assets) | 0.4% | 0.89% | 1.32% | -8.81% | 2.14% | -5.64% |
Assets 1 | 676.8 | 488.7 | 208.6 | 286.1 | 408.5 | 296.3 |
Book Value Per Share 2 | 14.00 | 14.60 | 15.00 | 10.30 | 11.50 | 9.250 |
Cash Flow per Share 2 | 0.9900 | 0.2500 | 0.0600 | 1.730 | 0.0100 | 2.740 |
Capex 1 | 2.77 | 3.97 | 4.81 | 5.04 | 21.1 | 0.63 |
Capex / Sales | 0.96% | 1.28% | 1.28% | 2% | 5.27% | 0.13% |
Announcement Date | 8/21/18 | 8/13/19 | 7/29/20 | 8/11/21 | 8/1/22 | 8/1/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+68.48% | 4.18M | |
+21.80% | 43.81B | |
+30.08% | 23.03B | |
+21.32% | 15.45B | |
+19.05% | 14.4B | |
+58.92% | 12.95B | |
-0.05% | 6.79B | |
-11.59% | 6.49B | |
-8.87% | 5.73B | |
+14.11% | 5.49B |
- Stock Market
- Equities
- GUJTERC6 Stock
- Financials Gujarat Terce Laboratories Limited